ACE2 and COVID-19: Several hypotheses have been proposed to describe the age-related differences in COVID-19 severity (3), including comorbidities, immune senescence, differential expression of the SARS-CoV-2 host receptor angiotensin-converting enzyme 2 (5), as well as variation in the inflammatory immune response; however, none appear to account for the strong correlation between COVID-19 severity and age.